Floris C. Loeff

BH3 Inhibitor Sensitivity and Bcl-2 Dependence in Primary Acute Lymphoblastic Leukemia Cells

Sarah E. Alford, Anisha Kothari, Floris C. Loeff et al. · Cancer Research · 2015 · 138 citations · Full text

Medicine, Oncology, Pharmacology +14

Development of a SARS-CoV-2 Total Antibody Assay and the Dynamics of Antibody Response over Time in Hospitalized and Nonhospitalized Patients with COVID-19

Erik H Vogelzang, Floris C. Loeff, Ninotska I. L. Derksen et al. · The Journal of Immunology · 2020 · 85 citations · Full text

Life Sciences, Immunology, Infectious Diseases +13

Patient‐centered dupilumab dosing regimen leads to successful dose reduction in persistently controlled atopic dermatitis

Lotte S. Spekhorst, Daphne S. Bakker, Julia Drylewicz et al. · Allergy · 2022 · 56 citations · Full text

Medicine, Dermatology, Pharmacology +13

Association of Serum Ustekinumab Levels With Clinical Response in Psoriasis

Teresa Tsakok, Nina Wilson, Nick Dand et al. · JAMA Dermatology · 2019 · 42 citations · Full text

Medicine, Dermatology, Pharmacology +15

Comprehensive evaluation of microneedle‐based intradermal adalimumab delivery <i>vs</i>. subcutaneous administration: results of a randomized controlled clinical trial

Justin Jacobse, Wouter ten Voorde, Anushka Tandon et al. · British Journal of Clinical Pharmacology · 2021 · 31 citations · Full text

Medicine, Dermatology, Pharmacology +14